Oramed Pharmaceuticals Inc (ORMP)

[navyvet]

I do agree that is way too much dilution, however they are not increasing outstanding shares to 250million but authorized to sell up to 250 million worth of stock on the open market. What will hopefully be around 10-15 million ish shares over time if positive results from COVID pill increase stock price. At most this would dilute us around 20 million shares.

I hope their thoughts are "let's have a huge offering available to us for when we increase greatly in stock price from successful trials so we can sell shares at $50-75 per stock and fund all future trials" but who knows the price point they plan on selling these at. The one good thing is so much of the boards compensation is in the form of stock so they need the stock price to rise for them to be able to cash in long term also.